Company profile
Marijuana Company of America, Inc.
OTC: MCOA · Healthcare · Drug Manufacturers - Specialty & Generic
#868 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ 22GM —SS 48
v0.1 · 25/100 weight · pillars only
↑ listing tenure, 3-yr revenue growth · ↓ return on equity, Altman-Z
Methodology →Revenue TTM
$429.0k
Rev growth YoY (TTM)
-72.4%
Net income (FY)
-$10.2M
Employees
7
as of 2026-08-25
Market cap
$2.2M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.0M$1.0M2021
Net income-$10.2M-$10.2M2021
Operating income-$4.7M-$4.7M2021
Total assets$8.0M$8.0M2021
Liabilities$7.7M$7.7M2021
Equity$230.9k$230.9k2021
Revenue trend
FY2017 – FY2021 · USD
FY17
FY18
FY18
FY19
FY20
FY21
FY21
Revenue by segment
Filed disclosures · FY2021
By product
Cdistro91%
Hemp Smart9%
By geography
Not disclosed.
The read
What is Marijuana Company of America, Inc.’s revenue?
Marijuana Company of America, Inc. booked $1.0M in FY2021 revenue, contracting 57% year over year — slower than 83% of Healthcare companies we track, at a -989.2% net margin.
Peers · Healthcare
Reflect Scientific, Inc.——First Choice Healthcare Solutions, Inc.26DOrgenesis Inc.——Dare Bioscience, Inc.36DSintx Technologies, Inc.35DEhouse Global, Inc.——Neighbors
Los Angeles →Key facts
CEOJesus Quintero
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersLos Angeles, CA
ExchangeOTC: MCOA
Employees7
IPO date1999-01-07
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.